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Abstract 
In mammalian cells the primary function of the endoplasmic reticulum is to synthesise and 
assemble membrane and secreted proteins.  As the main site of protein folding and post-
translational modification in the cell, the ER operates a highly conserved quality control system to 
ensure only correctly assembled proteins exit the ER, and misfolded and unfolded proteins are 
retained for disposal.  Any disruption in the equilibrium of the ER engages a multifaceted 
intracellular signalling pathway termed the unfolded protein response (UPR) to restore normal 
conditions in the cell.  A variety of pathological conditions can induce activation of the UPR, 
including neurodegenerative disorders such as Parkinson’s disease, metabolic disorders such as 
atherosclerosis, and conformational disorders such as cystic fibrosis.  Conformational disorders are 
characterised by mutations that modify the final structure of a protein and any cells that express 
abnormal protein risk functional impairment.  The monocyte is an important and long-lived 
immune cell and acts as a key immunological orchestrator, dictating the intensity and duration of 
the host immune response.  Monocytes expressing misfolded or unfolded protein may exhibit UPR 
activation and this can compromise the host immune system.  Here we describe in detail methods 
and protocols for the examination of UPR activation in peripheral blood monocytes.  This guide 
should provide new investigators to the field with a broad understanding of the tools required to 
investigate the UPR in the monocyte.   
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1. Introduction 
1.1. ER Stress and the Unfolded Protein Response (UPR) 
Newly synthesised secreted and transmembrane proteins are transported into the lumen of the 
endoplasmic reticulum (ER) where they are folded and correctly assembled.  The homeostasis of 
this organelle is vital to continued normal cell function and survival.  Perturbations that disrupt ER 
homeostasis, such as fluctuations in calcium storage or increased demand for protein folding arising 
from elevated production of secretory proteins, compromise ER protein folding capacity resulting in 
the accumulation of unfolded or misfolded protein within the lumen of the ER .  An imbalance 
between the load of unfolded proteins entering the ER and the ability of the ER to process this load 
is termed ER stress, and can be detrimental to cell survival.  ER stress can also be induced by a 
range of pathophysiological conditions, including stroke, ischaemia, diabetes, obesity, viral 
infection, and mutations that impair protein folding (Kaufman, 1999).   
To maintain homeostasis, the ER has evolved highly specific signalling pathways 
collectively referred to as the unfolded protein response (UPR), which strives to adapt for survival 
or induce apoptosis.  In the event of ER stress this protective pathway causes the translational 
attenuation of general protein synthesis, induces a transcriptional programme of ER-resident 
chaperones, and coordinates the degradation of misfolded proteins through ER-associated 
degradation (ERAD)(Mori, 2000).  Three proximal ER-resident transmembrane sensors, protein 
kinase RNA (PKR)-like ER kinase (PERK), inositol-requiring kinase 1 (IRE1), and activating 
transcription factor 6 (ATF6) form a tripartite management system that orchestrates the mammalian 
UPR (Ron and Walter, 2007).  The luminal domain of these three molecules is sequestered by the 
ER chaperone glucose-regulated protein 78 (GRP78), however, upon misfolded protein 
accumulation, GRP78 dissociates from PERK, IRE1, and ATF6, leading to their activation 
(Malhotra and Kaufman, 2007).  
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The most immediate step in the UPR is translational attenuation to prevent further 
accumulation of unfolded proteins in stressed cells.  This is mediated by PERK, through 
phosphorylation of eukaryotic initiation factor 2 (eIF2) at Serine 51 on its alpha subunit (eIF2α) 
(Harding et al., 1999).  While reducing the rate of protein synthesis and the protein load in the ER, 
eIF2α phosphorylation paradoxically promotes the translation of ATF4 mRNA, a basic leucine 
zipper (bZIP) transcription factor.  ATF4 induces a pro-survival programme of genes essential for 
amino acid import, glutathione biosynthesis, and resistance to oxidative stress (Harding et al., 
2003).   
The next step in the UPR employs IRE1 and ATF6, which regulate chaperone induction, 
expansion of the ER in response to increased client protein load and ER-associated degradation 
(ERAD) (Mori, 2000).  Upon UPR engagement, IRE1 is activated and its endoribonuclease activity 
causes removal of a 26-nucleotide intron from X-box binding protein 1 (XBP-1) mRNA 
(Tirasophon et al., 1998).  The spliced XBP-1 mRNA is translated into a potent bZIP transcription 
factor which translocates to the nucleus and acts as a key regulator of ER folding capacity.  
Concurrently, another bZIP transcription factor ATF6 is released from GRP78 and transported to 
the Golgi where it undergoes sequential cleavage by site-1 protease (S1P) and site-2 protease (S2P).  
Cleaved ATF6 cooperates with spliced XBP-1 to induce the expression of ER chaperones, ER 
quality control genes, folding enzymes and ERAD (Yoshida et al., 1998; Yoshida et al., 2001).  
ERAD ensures the removal of terminally misfolded proteins from the ER lumen to the cytoplasm 
for ultimate degradation by the ubiquitin-proteasome system (Travers et al., 2000).   
 
1.2. The Monocyte 
The human immune system has been historically divided into innate immunity and acquired or 
adaptive immunity. Monocytes and their multitude of differentiated offspring fulfil important 
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regulatory and effector roles in both arms of the immune system (Medzhitov and Janeway, 2000).  
Peripheral blood monocytes in the circulation migrate through blood vessel walls into various 
organs and differentiate into more specialised macrophages.  Monocytes and their macrophage 
progeny act as immunological orchestrators and serve three major functions, antigen presentation, 
phagocytosis, and immunomodulation (Dale et al., 2008).  Upon activation, monocytes and 
macrophages produce large amounts of cytokines and chemokines that recruit other immune cells 
such as neutrophils to sites of infection and inflammation.   
The first reports of ER stress and UPR activation in immune cells were in professional 
antibody-secreting plasma cells (Calfon et al., 2002).  This developmental ER stress is a natural 
consequence of the transition from B cell to plasma cell, which produces huge amounts of 
antibodies and requires a massive expansion in ER folding capacity (Iwakoshi et al., 2003).  
However, there is emerging evidence that UPR activation in monocytes and macrophages may play 
a role in the pathogenesis of a number of diseases.  In mouse models of atherosclerosis, 
macrophages overloaded with free cholesterol were shown to exhibit UPR activation (Li et al., 
2005), and monocytes from Type II diabetes patients showed elevated expression of GRP78 
(Komura et al., 2010).  Monocytes from cystic fibrosis (CF) patients were shown to be intrinsically 
abnormal in their cytokine responses (Zaman et al., 2004), but this can be reversed by inhibitors 
designed to prevent ∆F508 CFTR (cystic fibrosis transmembrane conductance regulator) 
degradation by ERAD and increase the secretion of CFTR (Vij et al., 2006).  In addition, work from 
this group has demonstrated intracellular accumulation of Z alpha-1 antitrypsin (AAT) in the ER of 
monocytes, and this causes sustained activation of the UPR with subsequent effects on immune 
function (Carroll et al., 2010).   
As the tissue macrophage can present a challenge in terms of isolation with unreliable 
sampling techniques or lengthy differentiation protocols from monocytes that risk cell activation, 
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the monocyte is a useful tool for investigating immune system derangement in a variety of 
disorders.   
 
2.1. Isolation, culture and treatment of peripheral blood monocytes 
In this section we will provide details for isolating monocytes from freshly-drawn whole blood from 
human donors.  It must be noted that studying the behaviour and function of human monocytes is a 
difficult undertaking.  Monocytes constantly observe their surroundings and swiftly react to 
changes, as is their nature.  The isolation, purification and culture of these cells in vitro can affect 
their phenotype, and care must be taken not to stimulate the cells.  The faster the isolation process 
the less chance of cell activation, and all buffers to be used should be pre-warmed to 37ºC.  We use 
Lymphoprep (Axis-Shield) to perform density gradient separation but Ficoll-Paque can also be used 
(Yeo et al., 2009).   
 
2.1.1. Required Materials 
• Lymphoprep (Axis-Shield) 
• 1X saline (0.9% NaCl) 
• Hanks Balanced Salt Solution (Biosciences) 
• EasySep Human CD14 positive selection kit (Stemcell Technologies) and EasySep magnet 
(Stemcell Technologies).  The kit is designed to isolate CD14 positive cells from fresh or 
previously frozen peripheral blood mononuclear cells by positive selection. 
• 5 mL polystyrene round bottom Falcon tube (BD Biosciences, product) 
• RPMI 1640 (Biosciences) supplemented with 10% FCS, 2% glutamine and 
penicillin/streptomycin (necessary for culturing monocytes) 
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• Thapsigargin (Molecular Probes) and tunicamycin (Sigma) for chemically inducing UPR 
activation.  Thapsigargin depletes calcium stores in the ER by inhibiting Ca2+ ATPase, 
while tunicamycin inhibits N-linked glycosylation of newly-synthesised proteins.  
 
2.1.2. Monocyte Isolation  
Mononuclear cells are isolated from venous peripheral blood obtained from donors by density 
gradient separation.  The blood must be collected in tubes containing an anticoagulant (EDTA or 
heparin).  Once drawn, blood is immediately placed in 50 mL tube and mixed with an equal 
volume of 0.9% NaCl (1X saline).  The diluted blood is then layered over Lymphoprep in a fresh 
50 mL tube.  For example, if 15 mL blood is obtained, mix with 15 mL 1X saline and then slowly 
and carefully layer over 15 mL Lymphoprep.  Alternatively, Lymphoprep can be under-layered 
below the diluted blood using a long pipette.  It is essential to avoid mixing of blood and 
Lymphoprep before centrifugation.  Centrifuge the Lymphoprep and blood at 800 x g for 10 
minutes at room temperature, with the centrifuge brake switched off.  After centrifugation, the 
mononuclear cells (which include monocytes and lymphocytes) form a distinct band at the 
blood/Lymphoprep interface. Carefully remove this band using a Pasteur pipette and place in a 
fresh tube.  Add an equal volume of 1X saline or HBSS to reduce the density of the solution and 
pellet these cells by gentle centrifugation (300 x g, 10 minutes).  Resuspend cells in 1mL EasySep 
recommended medium (1 mM EDTA, 2% Foetal Calf Serum in PBS Dulbecco) and transfer this 
1mL cell suspension to a 5 mL Falcon tube.  It is useful to count the number of mononuclear cells 
isolated at this step.  Monocytes should typically represent 10% of this total mononuclear fraction.   
From this point, we follow the EasySep CD14 kit protocol exactly as described in order to 
isolate monocytes from the mononuclear cell population.  In our experience, the most critical step 
in the Lymphoprep protocol is to ensure the centrifuge brake is switched off as this will ensure a 
tight band of mononuclear cells forms at the interface between serum and Lymphoprep.  Another 
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critical step is the careful layering of diluted blood over Lymphoprep to ensure no mixing occurs 
between the layers.  Leaving the centrifuge brake on or inefficient layering technique will result in 
a diffuse mononuclear band at the interface, and a poor monocyte yield.  Once monocytes are 
successfully isolated and counted they can be used in a variety of applications.  For example, if 
performing stimulation experiments, monocytes can be cultured in RPMI containing 10% (v/v) 
foetal calf serum (FCS) and 1% penicillin/streptomycin at 37°C in a 5% CO2 atmosphere for up to 
24 hours.  However, it is essential that monocytes are cultured in polypropylene tubes, and not 
polystyrene tubes, as polystyrene promote significant adherence and probable activation of 
monocytes.   
 
2.2. Enzyme-linked Immunosorbent Assay (ELISA) 
In addition to its role in maintaining ER homeostasis, it has become apparent that ER stress-induced 
UPR activation can influence the expression of a subset of inflammatory genes.  The spliced form 
of XBP-1 has been shown to control the production of IL-6 in the mouse B cell (Iwakoshi et al., 
2003).  XBP-1 was also shown to regulate the production of IFN-β in mouse macrophages 
subjected to ER stress (Smith et al., 2008).  Another study in a mouse model of atherosclerosis 
demonstrated that accumulation of free cholesterol in macrophages caused UPR activation and the 
secretion of significant amounts of TNF-α and IL-6 (Li et al., 2005).  Thus, the underestimated 
technique of ELISA is a reliable method of investigating an aberrant immune response in 
monocytes, often a consequence of UPR activation.  This quantitative method is highly 
reproducible, relatively cheap and easy to perform.  However, due to the large quantities of 
chemokines and cytokines secreted by monocytes, dilution of supernatants is often required and as 
little as 2 µL of supernatant can be sufficient in some cases, for example when assaying IL-8.  
Another application for ELISA is in the investigation of impaired secretion of specific proteins.  For 
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example, we have used this technique to show impaired secretion of AAT from monocytes isolated 
from alpha-1 antitrypsin deficient-individuals (Carroll et al., 2010).   
 
2.2.1. Required Materials for IL-8 ELISA 
• Monocyte supernatants 
• Immulon 2HB 96 well high-binding microtitre plates (Thermo Electron Corporation) 
• Voller’s coating buffer (100mM Bicarbonate/carbonate buffer, pH 9.6) 
• Wash buffer (0.05% Tween in PBS, pH 7.4) 
• Blocking buffer (1% BSA, 0.05% Tween in PBS, pH 7.4) 
• Recombinant human IL-8 (R&D Systems) 
• Monoclonal antibody to human IL-8 (MAB208, R&D Systems) 
• Biotinylated antibody to human IL-8 (BAF208, R&D Systems) 
• Streptavidin-horseradish peroxidase (HRP) (Biolegend) 
• ABTS substrate (Invitrogen) 
 
2.2.2. ELISA to Measure IL-8  
Supernatants are recovered and protein concentrations determined by ELISA with specific 
antibodies to the secreted protein of interest, in this example the chemokine IL-8.  The day before, a 
high-binding 96 well plate is coated with 100 µL per well of capture antibody (MAB208, 1/500 
dilution) diluted in Voller’s buffer – this is a key point.  If PBS is used as a diluent for the coating 
antibody, as stated in the manufacturer’s datasheet, the ELISA will not work.  The plate is sealed 
and incubated overnight at 4ºC.  Next day, each well is aspirated and filled with wash buffer, and 
repeated for a total of 3 washes using a multi-channel pipette.  Complete removal of the liquid at 
each step is achieved by inverting the plate and blotting on clean tissue paper.  Plate is blocked by 
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the addition of 200 µL of blocking buffer and incubated for 1 hour at room temperature.  Repeat 
aspiration and wash steps as before for 3 washes.  Plates are filled with 100 µL per well of 
monocyte supernatant (diluted).  Serial dilutions of recombinant human IL-8 in serum-free RPMI 
medium are performed to construct a standard curve (31.25 – 2000 pg/mL) and the plate is 
incubated for 2 hours at room temperature.  Plate is washed 3 times as before, 100 µL of the 
detection antibody (BAF208, 1/2500 dilution) is added to each well, and plate is incubated for a 
further 2 hours.  Next, plate is washed 3 times, 100 µL streptavidin-HRP is added (1/2500 dilution) 
and incubated for 30 minutes at room temperature.  Another 3 washes are performed, and the plate 
is incubated with 100 µL ABTS for 5 – 30 minutes in a dark box or cupboard protected from direct 
light.  It is useful to check the plate periodically for the development of a green colour, and once a 
significant colour is observed, measure the absorbance of each well at 405 nm on a Victor2 
microplate reader (Wallac).  Prepare a standard curve from the data produced from the serial 
dilutions with concentration on the X axis versus absorbance on the Y axis (linear).  Interpolate the 
concentration of the sample from this standard curve using Prism 4.0 statistical analysis software 
(GraphPad).  
As an ancillary step to ELISA, cytokine arrays can be employed to measure multiple 
proteins in the monocyte supernatants (RayBiotech, Inc).  This technique, although expensive, 
allows the semi-quantitative measurement of over 100 cytokines, chemokines, proteases, 
antiproteases, and growth factors from a single sample.  Any potential leads can then be confirmed 
by ELISA or quantitative RT-PCR.  
 
2.3. RNA Isolation, cDNA synthesis and RT-PCR 
There are inherent difficulties involved in measuring the activation of the major UPR orchestrators.  
The phosphorylation of PERK and IRE1 and the proteolytic cleavage of ATF6 are hallmarks of 
their activation.  However, these proteins are expressed at very low levels and detection is hindered 
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by a lack of high quality commercial antibodies.  As surrogate markers of activation, a number of 
UPR genes downstream of these proximal sensors have been identified, and can be easily measured 
by real-time PCR.  For example, ATF4 is selectively activated by PERK-induced phosphorylation 
of eIF2α, and while IRE1 activation is difficult to reproducibly and consistently measure, the 
processing of unspliced XBP-1 mRNA into mature spliced XBP-1 (sXBP-1) mRNA is a 
convenient, widely-used indicator of IRE1 activation (Marciniak et al., 2004).  The expression of 
several other UPR-responsive genes can be easily measured in this way, including calreticulin, 
calnexin, CHOP, ERdj5, p97/VCP, GRP78, and GRP94.   
 
2.3.1. Required Materials  
• TRI reagent (Sigma) 
• QuantiTect reverse-transcription cDNA synthesis kit (Qiagen) 
• SYBR Green I Master mix (Roche) for real-time quantitative RT-PCR 
• GoTaq Green Master mix (Promega) for conventional RT-PCR 
• Oligonucleotide primers (Eurofins MWG Operon) 
 
2.3.2. Real-time PCR  
For analysis of UPR markers, 500 µL TRI reagent is added to the isolated monocytes (in a fume 
hood) and RNA is recovered according to the manufacturer’s instructions.  We prefer to resuspend 
RNA in 0.1% diethylpyrocarbonate-treated (DEPC) water, as DEPC is an efficient, nonspecific 
inhibitor of RNases.  Store the isolated RNA at -80ºC and avoid repeated freeze-thaw cycles.  
Quantify RNA concentration on a spectrophotometer prior to each separate cDNA synthesis.  Equal 
quantities of RNA are then reverse transcribed into cDNA using the Quantitect Reverse 
Transcription kit.  The resulting cDNA is used as the template for quantitative real-time PCR.  
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Oligonucleotide primers are synthesised specific to each target UPR gene and quantitative PCR 
reactions performed containing 2 µl template cDNA, 10 µl 2X SYBR Green I master mix, 10 
picomoles of forward and reverse primers, and nuclease-free water to give a final volume of 20 µl.  
Amplification is performed on the Roche LightCycler 480 PCR system with the expression of target 
genes relative to the housekeeping gene β–actin determined using the 2-∆∆CT method (Livak and 
Schmittgen, 2001)(Figure 1.1.).   
 
 
Figure 1.1. Quantitative RT-PCR analysis of calreticulin (CRT), sXBP-1 and GRP78 mRNA 
induction in peripheral blood monocytes after treatment with thapsigargin for 4 hours.  
 
2.3.3. Analysis of XBP-1 mRNA cleavage 
XBP-1 mRNA splicing is analysed in our laboratory using a conventional semi-quantitative RT-
PCR assay developed by Harding et al. (Calfon et al., 2002).  RNA is isolated using TRI reagent 
and cDNA synthesised as described.  The resulting cDNA is template in a reaction with GoTaq 
master mix and specific XBP-1 forward and reverse primers.  The primers used to amplify XBP-1 
cDNA: forward 5’-AAACAGAGTAGCAGCTCAGACTGC-3’; reverse 5’-
TCCTTCTGGGTAGACCTCTGGGA-3’.  PCR products are resolved on a 2.5% agarose gel with 
unspliced XBP-1 yielding a product of 480 bp, while spliced XBP-1 is 454 bp.  Agarose gel 
electrophoresis may need to be performed for up to 2 hours to detect an appreciable difference 
between spliced and unspliced XBP-1.   
 
2.4. Detection of UPR Markers by Immunoblotting 
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As previously described, the phosphorylation of PERK and IRE1 and the proteolytic cleavage of 
ATF6 are difficult to detect.  However, the activation of a number of other downstream UPR 
proteins such as ATF4, CHOP, GRP78, and p97/VCP can be detected by Western blotting.  
 
2.4.1. Immunoblotting Method 
Monocytes are isolated as described, pelleted by gentle centrifugation (400 x g, 5 minutes) and cells 
resuspended in 1 mL hypotonic buffer (10 mM Hepes (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 
mM PMSF and 0.5 mM DTT) (Sigma).  Cells are lysed for 30 minutes on ice before centrifugation 
at 14,000 x g for 10 min at 4°C.  The supernatant is then recovered for immunoblotting and stored at 
-80°C until required.  Protein concentration in the monocyte lysate is determined by the method of 
Bradford (Bradford, 1976).  Whole cell lysates are separated by electrophoresis on SDS-
polyacrylamide gel and transferred to a PVDF membrane (Sigma).  The percent polyacrylamide 
used will depend on the size of the UPR protein being investigated.  PVDF membranes can be cut to 
investigate the levels of multiple proteins if there is sufficient difference in the size of the proteins 
being examined, and this can eliminate the need to strip and reprobe membranes.  Non-specific 
binding is blocked with 5% bovine serum albumin (Sigma) in PBS containing 0.1% Tween-20 
(Sigma).  Immunoreactive proteins are detected by incubating the membrane with specific 
antibodies to UPR proteins of interest, for example the excellent anti-KDEL antibody which detects 
GRP78 and GRP94 (Stressgen), and comparing with appropriate loading controls such as GAPDH 
or -actin.   
 
2.5. Immunofluorescence  
Immunofluorescence is a powerful tool that can be used to demonstrate the accumulation of 
misfolded protein within the ER.  For example, we have used this technique to show intracellular 
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accumulation of AAT within the ER of monocytes from alpha-1 antitrypsin deficient-individuals, as 
well as increased GRP78 and GRP94 expression (Carroll et al., 2010).   
 
2.5.1. Required Materials 
• Poly-L-lysine coated slides (Sigma) 
• 4% Paraformaldehyde (Sigma) diluted in PBS 
• 0.2% Triton X-100 diluted in PBS (permeabilisation buffer) 
• 4% BSA/1% gelatin in PBS (blocking buffer) 
• Vectashield (Vector Laboratories)  
 
2.5.2. Co-localisation using Immunofluorescence 
This method is used to investigate AAT localisation to the ER by double-staining monocytes with 
an antibody to AAT and an antibody to ER-resident chaperones containing the tetrapeptide KDEL 
motif.  Monocytes are isolated as described and 100 µL of monocyte suspension pipetted onto a 
poly-L-lysine glass slide (‘P’ side up).  Score the slide with a diamond pen to indicate the position 
of cells.  Poly-L-lysine coated slides should be used as they provide higher adhesion, reducing the 
chances of tissue or cell loss during processing.  The cells are allowed to adhere to slide for 10 
minutes and then fixed in 4% paraformaldehyde. The cell membranes are disrupted in 0.2% Triton 
X-100. Non-specific binding of antibodies and fluorescent conjugates are blocked by pre-incubation 
in 4% BSA/1% gelatin.  Co-localisation of AAT and ER-specific chaperones is detected by 
immunofluorescence using goat polyclonal anti-AAT-FITC (Abcam) and mouse monoclonal anti-
KDEL (Stressgen), with an anti-mouse tetramethylrhodamine isothiocyanate (TRITC) secondary 
conjugate (Abcam) for visualization of the anti-KDEL antibody.  PBS washes (x 3) are performed 
after each incubation, and ensure the addition and removal of solutions is performed carefully in the 
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corner of the slides so as not to disturb or dislodge the monocytes.  Cells are then mounted in 
Vectashield, containing 4’, 6-diamidino-2-phenylindole di-lactate (DAPI), and examined using a 
LSM510 Meta laser scanning confocal microscope (Zeiss).  Images are captured at ×63 
magnification and ×4 zoom with excitation wavelengths for FITC, TRITC and DAPI of 488 nm, 
543 nm and 364 nm respectively (Figure 1.2.).   
 
 
Figure 1.2. Intracellular accumulation of AAT and increased KDEL expression in the ER of ZZ 
monocytes.  The subcellular distribution of AAT in monocytes isolated from MM (normal) and ZZ 
(AAT-deficient) individuals was determined by immunofluorescence using antibodies for AAT 
(green) and the ER marker KDEL (red), with colocalisation indicated by yellow staining.  Nuclei 
were stained with DAPI (blue).  Imaging was acquired using a Zeiss LSM510 Meta confocal 
microscope and the images presented are single focal plane scans of 1 µm depth at the mid section 
of the fixed cells.   
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Figure 1.1. Quantitative RT-PCR analysis of calreticulin (CRT), sXBP-1 and GRP78 mRNA 
induction in peripheral blood monocytes after treatment with thapsigargin for 4 hours.  
 
 
Figure 1.2. Intracellular accumulation of AAT and increased KDEL expression in the ER of ZZ 
monocytes.  The subcellular distribution of AAT in monocytes isolated from MM (normal) and ZZ 
(AAT-deficient) individuals was determined by immunofluorescence using antibodies for AAT 
(green) and the ER marker KDEL (red), with colocalisation indicated by yellow staining.  Nuclei 
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were stained with DAPI (blue).  Imaging was acquired using a Zeiss LSM510 Meta confocal 
microscope and the images presented are single focal plane scans of 1 µm depth at the mid section 
of the fixed cells.   
 
